AVLN

Avalyn Pharma Inc.CIK 1540171 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for AVLN PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for AVLN

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Meyer Robert J.	Director	2	$0	$0	2026-09-15
FMR LLC	10% Owner	10	$0	$0	2026-05-01
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.	10% Owner	3	$0	$0	2026-05-01
Carroll Jill	Director	5	$5.00M	$0	2026-05-01
George Simeon	10% Owner	10	$10.00M	$0	2026-05-01
Novo Holdings A/S	10% Owner	7	$10.00M	$0	2026-05-01
Lavelle Erin	Director	1	$0	$0	2026-04-30
Carlson Douglas R	Chief Financial Officer	1	$0	$0	2026-04-30
Golden Adam H.	General Counsel	1	$0	$0	2026-04-29
Lazarus Howard	Chief Medical Officer	1	$0	$0	2026-04-29
Rhodes Melissa	Chief Operating Officer	1	$0	$0	2026-04-29
Baranowski Lyn	Chief Executive Officer	1	$0	$0	2026-04-29
Haviland Kate	Director	1	$0	$0	2026-04-29
Congleton Jon	Director	1	$0	$0	2026-04-29
Turner Heather D	Director	1	$0	$0	2026-04-29

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Meyer Robert J.	Director	A Award deriv	2026-09-15	2026-09-17	31,182	—	$0	31,182	SEC↗
Meyer Robert J.	Director	A Award deriv	2026-09-15	2026-09-17	31,182	—	$0	31,182	SEC↗
Wellington Biomedical Innovati	10% Owner	C Conversion deriv	2026-05-01	2026-05-01	4,060,259	—	$0	0	SEC↗
Wellington Biomedical Innovati	10% Owner	C Conversion deriv	2026-05-01	2026-05-01	20,482,289	—	$0	0	SEC↗
George Simeon	10% Owner	C Conversion deriv	2026-05-01	2026-05-01	27,309,719	—	$0	0	SEC↗
George Simeon	10% Owner	C Conversion deriv	2026-05-01	2026-05-01	9,418,560	—	$0	0	SEC↗
George Simeon	10% Owner	C Conversion deriv	2026-05-01	2026-05-01	9,418,561	—	$0	0	SEC↗
George Simeon	10% Owner	C Conversion deriv	2026-05-01	2026-05-01	6,827,429	—	$0	0	SEC↗
Carroll Jill	Director	C Conversion deriv	2026-05-01	2026-05-01	9,418,561	—	$0	0	SEC↗
Carroll Jill	Director	C Conversion deriv	2026-05-01	2026-05-01	27,309,719	—	$0	0	SEC↗
FMR LLC	10% Owner	C Conversion deriv	2026-05-01	2026-05-05	377,948	—	$0	0	SEC↗
FMR LLC	10% Owner	C Conversion deriv	2026-05-01	2026-05-05	225,843	—	$0	0	SEC↗
FMR LLC	10% Owner	C Conversion deriv	2026-05-01	2026-05-05	872,868	—	$0	0	SEC↗
FMR LLC	10% Owner	C Conversion deriv	2026-05-01	2026-05-05	80,291	—	$0	0	SEC↗
FMR LLC	10% Owner	C Conversion deriv	2026-05-01	2026-05-05	727,585	—	$0	0	SEC↗
Novo Holdings A/S	10% Owner	C Conversion deriv	2026-05-01	2026-05-05	12,558,081	—	$0	0	SEC↗
Novo Holdings A/S	10% Owner	C Conversion deriv	2026-05-01	2026-05-05	5,587,603	—	$0	0	SEC↗
Novo Holdings A/S	10% Owner	C Conversion deriv	2026-05-01	2026-05-05	18,000,000	—	$0	0	SEC↗
Novo Holdings A/S	10% Owner	C Conversion deriv	2026-05-01	2026-05-05	1,986,369	—	$0	0	SEC↗
Novo Holdings A/S	10% Owner	C Conversion deriv	2026-05-01	2026-05-05	25,899,284	—	$0	0	SEC↗
Wellington Biomedical Innovati	10% Owner	C Conversion	2026-05-01	2026-05-01	1,275,486	—	$0	1,275,486	SEC↗
George Simeon	10% Owner	C Conversion	2026-05-01	2026-05-01	489,486	—	$0	844,310	SEC↗
George Simeon	10% Owner	C Conversion	2026-05-01	2026-05-01	1,419,298	—	$0	1,419,298	SEC↗
George Simeon	10% Owner	C Conversion	2026-05-01	2026-05-01	489,486	—	$0	1,908,784	SEC↗
George Simeon	10% Owner	P Buy	2026-05-01	2026-05-01	277,778	$18.00	$5.00M	2,186,562	SEC↗
George Simeon	10% Owner	C Conversion	2026-05-01	2026-05-01	354,824	—	$0	354,824	SEC↗
George Simeon	10% Owner	P Buy	2026-05-01	2026-05-01	277,777	$18.00	$5.00M	1,122,087	SEC↗
Carroll Jill	Director	C Conversion	2026-05-01	2026-05-01	1,419,298	—	$0	1,419,298	SEC↗
Carroll Jill	Director	C Conversion	2026-05-01	2026-05-01	489,486	—	$0	1,908,784	SEC↗
Carroll Jill	Director	P Buy	2026-05-01	2026-05-01	277,778	$18.00	$5.00M	2,186,562	SEC↗
FMR LLC	10% Owner	C Conversion	2026-05-01	2026-05-05	727,585	—	$0	727,585	SEC↗
FMR LLC	10% Owner	C Conversion	2026-05-01	2026-05-05	80,291	—	$0	807,876	SEC↗
FMR LLC	10% Owner	C Conversion	2026-05-01	2026-05-05	872,868	—	$0	1,680,744	SEC↗
FMR LLC	10% Owner	C Conversion	2026-05-01	2026-05-05	225,843	—	$0	1,906,587	SEC↗
FMR LLC	10% Owner	C Conversion	2026-05-01	2026-05-05	377,948	—	$0	2,284,535	SEC↗
Novo Holdings A/S	10% Owner	P Buy	2026-05-01	2026-05-05	555,555	$18.00	$10.00M	3,883,289	SEC↗
Novo Holdings A/S	10% Owner	C Conversion	2026-05-01	2026-05-05	3,327,734	—	$0	3,327,734	SEC↗
Lavelle Erin	Director	A Award deriv	2026-04-30	2026-05-01	26,978	—	$0	26,978	SEC↗
Carlson Douglas R	Chief Financial Officer	A Award deriv	2026-04-30	2026-05-01	211,975	—	$0	211,975	SEC↗
Baranowski Lyn	Chief Executive Officer	A Award deriv	2026-04-29	2026-05-01	501,033	—	$0	501,033	SEC↗
Lazarus Howard	Chief Medical Officer	A Award deriv	2026-04-29	2026-05-01	211,975	—	$0	211,975	SEC↗
Haviland Kate	Director	A Award deriv	2026-04-29	2026-05-01	26,978	—	$0	26,978	SEC↗
Rhodes Melissa	Chief Operating Officer	A Award deriv	2026-04-29	2026-05-01	211,975	—	$0	211,975	SEC↗
Turner Heather D	Director	A Award deriv	2026-04-29	2026-05-01	26,978	—	$0	26,978	SEC↗
Congleton Jon	Director	A Award deriv	2026-04-29	2026-05-01	26,978	—	$0	26,978	SEC↗
Golden Adam H.	General Counsel	A Award deriv	2026-04-29	2026-05-04	254,891	—	$0	254,891	SEC↗